Tuspetinib (HM-43239) is an active pharmaceutical ingredient under investigation in clinical trials for relapsed or refractory acute myeloid leukemia. Its structure features aromatic rings, amines, and a halogen atom, indicating a complex, polar compound.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Tuspetinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
HM43239 monohydrate
pharmaceutical raw material
Sodium sulfapyridazine
pharmaceutical raw material
Zucapsaicin
pharmaceutical raw material
Gemfibrozil
pharmaceutical raw material
FAP-2286?
pharmaceutical raw material
5-chloro-N-[3-cyclopropyl-5-[[(3S,5R)-3,5-dimethylpiperazin-1-yl]methyl]phenyl]-4-(6-methyl-1H-indol-3-yl)pyrimidin-2-amine
FZLSDZZNPXXBBB-KDURUIRLSA-N
C[C@@H]1CN(C[C@@H](N1)C)CC2=CC(=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=C4C=CC(=C5)C)Cl)C6CC6
Sourcing Tuspetinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.